News & Opinion


Gout Drug Associated with Cardiovascular Risk

November 20, 2017

The gout drug Uloric (febuxostat) appears to have a higher rate of heart-related death when compared with another gout medication, according to a new FDA safety alert.

Following Uloric’s approval in 2009, the FDA required its manufacturer, Takeda Pharmaceuticals, to conduct a postmarket safety trial because clinical Continue Reading →

Quick Hits: FDA Approves ‘Smart Pill,’ Seniors Can Develop Heart Problems from Antipsychotics

November 16, 2017
Quick Hits: Americans Open to Non-Drug Pain Treatments, Psychiatric Drugs’ Impact on Cognition and Epilepsy Drugs and Pregnancy

The FDA approved a pill with a sensor that sends a digital signal to an external patch that sends a message to a phone app to confirm that a patient has taken the medication. Abilify MyCite is used treat schizophrenia, bipolar I disorder and depression.

While the manufacturer touts Continue Reading →

FDA Issues Warning on Kratom

November 15, 2017

The FDA issued a public health advisory concerning the risks associated with the use of kratom. The plant, which grows in Thailand, Malaysia, Indonesia and Papua New Guinea, is being turned into medical and recreational products that are increasingly being imported into the US. Kratom is used Continue Reading →

Zapping Dry Eyes – Through the Nose

November 14, 2017

A new handheld nasal stimulator that is inserted through the nose is providing significant relief for people who suffer from dry eyes, according to a study presented at the annual meeting of the American Academy of Ophthalmology.

TrueTear is a neurostimulator device that produces more tears for dry-eye sufferers. Continue Reading →

For Seasonal Allergies, Taking 1 Drug is Better Than 2

November 13, 2017

When it comes to treating seasonal allergies, taking only 1 medication is preferable to taking 2, according to allergists.

A new clinical guideline issued by a task force of the American College of Allergy, Asthma and Immunology says that initial treatment of seasonal allergic rhinitis should be Continue Reading →

Quick Hits: Warfarin May Lower Cancer Risk, Using ‘Big Data’ to Predict Side Effects & More

November 9, 2017
Quick Hits: Americans Open to Non-Drug Pain Treatments, Psychiatric Drugs’ Impact on Cognition and Epilepsy Drugs and Pregnancy

People over 50 who take the blood thinner warfarin may have a lower risk of developing cancer. Researchers from the University of Bergen, Norway, looked at the medical records of around 93,000 people taking the drug and compared them with with more than 1.1 million people not taking warfarin (Coumadin). Continue Reading →

7 Deaths Linked to EpiPen Failures

November 8, 2017

Failures of the potentially life-saving auto-injector EpiPen (epinephrine), used when someone has a severe allergic reaction, to work properly have led to 7 deaths so far this year, according to data from the FDA.

Bloomberg News reports that through mid-September of this year, there were 228 reports Continue Reading →